Profile number 105985

Making cancer obvious. Diagnostics using minimally invasive imaging technology!

15/08/2023 Date added

Located in


Also interesting for this region (s)

  • Noord-Nederland
  • Oost-Nederland
  • Midden-Nederland
  • West-Nederland

General information



Type of company


Legal entity

Private limited company

Type of transaction

To be determined

Life phase enterprise


Employees in FTE

5 - 10

Type of buyer


Financial information

Turnover last financial year

€ 0 - € 100.000

Asking price

€ 1.000.000 - € 2.500.000

Earnings before taxes

€ 0 - € 100.000

Company history/background

Worldwide, the incidence of cancer is growing, as life expectancy increases. Current imaging tools have their limitations as they are not suitable to provide the necessary information. In particular, information on the tissue structure on mm scale at high resolution is missing to make cancer treatment radically more accurate, faster and personalized. Specially for bladder cancer (BC) this is the case, but also for colon cancer, lung cancer and cancer in the prostate. BC is one of the most costly cancer types worldwide. 

The enterprise has an excellent team with demonstrated experienceto make this OCT catheter a success. The CEO has successfully founded and sold a tech start-up in another major industry. The members of the leadership team are biomedical engineers with expertise in imaging technologies and medical devices. The organization has in-house software development and an experienced regulatory expert. The team is promoted by leading scientists and supported by a dozen urologists throughout Europe, as part of an early adopter program. Funding up to now is mainly provided by business angels with relevant industry expertise.


Company activities

Cancer treatment technology that will drastically improve cancer treatment and care.  With the firms forward looking OCT catheter the urologist will be able to visualise the anatomical bladder wall structure in real time during the standard cystoscopy examination, with an incredible resolution of only a few micrometers and allowing the detection of very early tumors. This will personalize treatment options, increase the quality of the patients lives and reduce health care costs.

The urologists who reviewed the technology see this as a likely game changer in the treatment of BC patients, with the potential to become the gold standard. Experts from other clinical areas also express great interest in this new development.

  1. Market

Annually >500.000 people are diagnosed with BC. In up to 80% recurrences will occur, resulting in lifelong follow ups. By using image guided therapy the amount of unneeded bladder removals can be significantly decreased (currently 20%) and the number of unnecessary follow-up surgeries can be reduced (currently up to 50%). In the BC market, we expect to sell 50.000 catheters per year in 5 years after the first sale, representing a turn over of ~€30M

Unique selling points
  • The firms imaging platform makes one stop diagnosis and treatment possible. Combined with AI, a powerful diagnosis tool is created, which can distinguish between different benign and malign tissue types. Finally, photonics based localization enables robotic surgery.
  • It’s a minimally invasive imaging catheter that allows doctors to see cancerous tissue otherwise hidden within the organ walls.With this device doctors will be able to discover bladder, colon, lung and prostate cancer already at the 1st consult, in real time.
  • The high resolution tissue structure image provided with this solution supports the urologist in a more accurate, faster and personalized treatment.

Making cancer obvious. Diagnostics using minimally invasive imaging technology!
For sale
0 - 100.000
1.000.000 - 2.500.000
Get in contact Save to favourites

Interested or more information?

You can get in touch with the profile provider free of charge and without obligation. After entering your e-mail address you can express your interest or request more information. The data requested by us is intended solely for making contact and will therefore be treated discretely by the receiving party.

This is how you get in touch:

  • Enter your e-mail address below
  • If it is already known, log in or click on forgot password
  • Then fill in the response form and send it
  • We check your response and send it to the provider
  • The provider will contact you within 7 days
  • Didn't hear anything after 7 days? Let us know

Accompanying text for provider

  • Ask your questions
  • Indicate where your interest comes from
  • Tell something about your background

Available capital

Please note: financing a business acquisition requires a minimum of 25% own contribution.

This data is only intended for establishing contact. The data is checked by us before we send it to the provider. Responses that are incomplete or contain incorrect information will not be forwarded.

Postal code

Please enter your postal code and house number and the address will be filled in automatically.


Make sure you enter the right data, otherwise the owner cannot contact you.

Phone number

If we contact you, we will always do so confidentially. Please be sure to enter the right number.

Mobile phone number

If we contact you, we will always do so confidentially. Please be sure to enter the right number.

After posting this reaction, an account will be created for you automatically. From here you can easily manage these and any subsequent responses. Create a password below. The password must be at least 6 characters long.